Title: Inhibition of Vascular Endothelial Growth Factor Reduces Scar Formation after Glaucoma Filtration Surgery
Authors: Li, Z
Van Bergen, Tine ×
Van de Veire, Sara
Van de Vel, Isabelle
Moreau, Huberte
Dewerchin, Mieke
Maudgal, Prabhat
Zeyen, Thierry
Spileers, Werner
Moons, Lieve
Stalmans, Ingeborg #
Issue Date: May-2009
Publisher: Association for Research in Vision and Ophthalmology
Series Title: Investigative Ophthalmology & Visual Science vol:50 issue:11 pages:5217-5225
Abstract: PURPOSE: Filtration failure due to excessive post-operative scarring remains a major problem after glaucoma surgery. We have investigated whether glaucoma and filtration surgery are associated with increased levels of vascular endothelial growth factor (VEGF), and whether a humanized monoclonal antibody against VEGF, bevacizumab (AvastinTM, Genentech), can reduce post-operative scar formation and improve surgical outcome. METHODS: The levels of VEGF in samples of aqueous humour were measured by ELISA. The expression of the VEGF receptors Flt-1 and KDR was analysed in cultured Tenon fibroblasts by real-time RT-PCR and western blotting. The effect of VEGF and bevacizumab on Tenon fibroblasts in vitro was determined using a proliferation assay. The in vivo effect of the antibody was investigated in a rabbit model of trabeculectomy by measuring the intraocular pressure (IOP) and bleb area, and by immunohistological analysis of angiogenesis, inflammation, and fibrosis. RESULTS: VEGF levels were increased significantly in the aqueous humour of glaucoma patients and rabbits that had undergone surgery. Both VEGF receptors were expressed on Tenon fibroblasts. Fibroblast proliferation in vitro was stimulated by delivery of VEGF, and was inhibited by administration of bevacizumab. The antibody also reduced angiogenesis and collagen deposition significantly, and improved the outcome of glaucoma surgery in rabbits. CONCLUSIONS: VEGF was up-regulated in the aqueous humour of glaucoma patients and in the rabbit model, and it stimulated fibroblast proliferation in vitro. This suggests that it is involved in the scarring processs after filtration surgery. Bevacizumab reduced the proliferation of fibroblasts in vitro and improved surgical outcome.
ISSN: 0146-0404
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Animal Physiology and Neurobiology Section - miscellaneous
Research Group Ophthalmology
Molecular and Vascular Biology
Laboratory of Angiogenesis and Vascular Metabolism (Vesalius Research Center) (+)
× corresponding author
# (joint) last author

Files in This Item:
File Description Status SizeFormat
Li et al._2009_Investigative Opthamol Visual Sci_vol50_p5217-5225.pdf Published 643KbAdobe PDFView/Open Request a copy

These files are only available to some KU Leuven Association staff members


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science